Biomedical Textiles Market Report 2026

Biomedical Textiles Market Overview

• Biomedical Textiles market size has reached to $17.69 billion in 2025 • Expected to grow to $27.74 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Healthcare Expenditure Boosts Demand For Biomedical Textiles • Market Trend: Smart-Textile Platform In Biomedical Textiles Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biomedical Textiles Market?

Biomedical textiles are fibrous textile constructions made from synthetic or natural materials. These advanced materials resist various fungi, fire, bacteria, dirt, and water. Biomedical textiles are used as a medical device inside or outside the biological environment to improve the patient's health. The main product types in biomedical textiles are non-implantable and implantable. The non-implantable biomedical textiles are used for external wound dressings. Non-implantable biomedical textiles are substances applied externally to the body that may or may not come into contact with the skin. These are made using various fabrics such as non-woven biomedical textiles, woven biomedical textiles, and knitted biomedical textiles and fiber type includes non-biodegradable and biodegradable. The main applications include ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and treatment, and other applications that are used by hospitals, ambulatory centers, clinics, community healthcare, and other end users.

What Is The Biomedical Textiles Market Growth Forecast?

The biomedical textiles market size is expected to see strong growth in the next few years. It will grow to $27.74 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of bioresorbable materials, rising demand for minimally invasive surgical solutions, expansion of smart healthcare textiles, growing investments in medical device innovation, increasing focus on infection prevention. Major trends in the forecast period include increasing adoption of advanced implantable textile materials, rising demand for antimicrobial medical fabrics, growing use of biodegradable biomedical fibers, expansion of smart and functional medical textiles, enhanced focus on patient comfort and safety.

What Is The Driver Of The Biomedical Textiles Market?

The rising healthcare expenditure is expected to propel the growth of the biomedical textiles market going forward. Healthcare expenditure refers to the amount of money spent on healthcare goods and services, including medical equipment, pharmaceuticals, hospital care, physician services, and other healthcare-related expenses. It directly influences investment in advanced medical treatments, technologies, and healthcare infrastructure. The rising healthcare expenditure led to investments in advanced medical treatments and technologies, which has further contributed to the demand for specialized biomedical textile materials. For instance, in November 2025, according to Organisation for Economic Co-operation and Development, a France-based intergovernmental economic organization, reported that in 2024, average health spending in OECD countries was estimated to stand at nearly USD 6000 per capita (when adjusted for differences in purchasing power). The United States was the highest spender. Therefore, rising healthcare expenditures are driving the growth of the biomedical textiles industry.

Key Players In The Global Biomedical Textiles Market

Major companies operating in the biomedical textiles market are Confluent Medical Technologies, Cardinal Health Inc, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Smith & Nephew PLC, Medline Industries Inc, 3M Company, ATEX Technologies, Integra Life Sciences Corporation, Paul Hartmann AG, BSN Medical GmbH, Bally Ribbon Mills, Asahi Kasei Corporation, Freudenberg Medical LLC, Halyard Health, Kimberly-Clark Corporation, Milliken & Company, Mölnlycke Health Care AB, Precision Fabrics Group Inc., Secant Group LLC, Stradis Healthcare, Tietex International Ltd., Trelleborg AB, Vestagen Protective Technologies Inc., W.L. Gore & Associates Inc., Welspun Group, Zimmer Biomet Holdings

Global Biomedical Textiles Market Trends and Insights

Major companies operating in the biomedical textiles market are focused on adopting strategic collaborations with one another to introduce smart textile platforms for developing biomedical textiles. These partnerships allow companies to leverage each other's expertise in developing innovative platforms for integrating medicine, wellness, and health benefits into clothing. For instance, in August 2023, Nufabrx, a US-based biomedical textile company, partnered with Enventys Partners, a US-based vertically integrated product development, crowdfunding, and inbound marketing agency, to introduce HealthWear, a groundbreaking platform technology that integrates medicine, wellness, and health benefits into clothing. The active chemicals in textile goods are immediately included in this proprietary smart-textile platform. The final garments, when knitted into the composition of HealthWear, reliably apply topical medications in small amounts to the skin, which are activated by body heat and/or moisture. Even after multiple wears, uses, and laundries, garments constructed with HealthWear technology continue to administer a therapeutic level of care.

What Are Latest Mergers And Acquisitions In The Biomedical Textiles Market?

In March 2023, Riverpoint Medical, a U.S.-based medical device company specializing in surgical scaffolds and textile-based implants, entered into an exclusive licensing agreement with DSM Biomedical to use its proprietary osteoconductive (OC) coating technology. With this partnership, Riverpoint aims to incorporate DSM’s OC coating into its implantable textile-based scaffolds and grafts to promote bone in-growth and enhance regenerative performance. DSM Biomedical, a Netherlands-based biomaterials company, provides advanced osteoconductive coating technologies tailored for medical implants and tissue engineering applications, enabling enhanced cellular integration and improved long-term stability for textile implants.

What Defines the Biomedical Textiles Market?

The biomedical textiles market consists of sales of textiles for sutures & ligatures, vascular implants, soft tissue implants, hard tissue implants and hernia repair. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biomedical Textiles Market Report 2026?

The biomedical textiles market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biomedical textiles industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.